2014 Analysis of Henkel
US$ 1,960.00
This strategic assessment of Henkel, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...
November 2013
60 pages
2014 Analysis of RPM
US$ 1,960.00
This strategic assessment of RPM, one of the world’s leading paints and coatings companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...
November 2013
31 pages
2014 Analysis of Bayer in the Worldwide Agrochemicals Market
US$ 1,960.00
This strategic assessment of Bayer, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive ...
November 2013
66 pages
2014 Analysis of Dow Chemical in the Worldwide Agrochemicals Market
US$ 1,960.00
This strategic assessment of Dow Chemical, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...
November 2013
59 pages
2014 Analysis of Syngenta
US$ 1,960.00
This strategic assessment of Syngenta, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a ...
November 2013
25 pages
2014 Analysis of FMC in the Worldwide Agrochemicals Market
US$ 1,960.00
This strategic assessment of FMC, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive ...
November 2013
40 pages
2014 Analysis of Firmenich
US$ 1,960.00
This strategic assessment of Firmenich, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...
November 2013
47 pages
2014 Analysis of Givaudan
US$ 1,960.00
This strategic assessment of Givaudan, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...
November 2013
50 pages
2014 Analysis of T. Hasegawa
US$ 1,960.00
This strategic assessment of T. Hasegawa, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...
November 2013
33 pages
2014 Analysis of IFF
US$ 1,960.00
This strategic assessment of IFF, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...
November 2013
65 pages
2014 Analysis of Mane
US$ 1,960.00
This strategic assessment of Mane, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...
November 2013
26 pages
2014 Analysis of Robertet
US$ 1,960.00
This strategic assessment of Robertet, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...
November 2013
21 pages
2014 Analysis of Sensient
US$ 1,960.00
This strategic assessment of Sensient, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...
November 2013
45 pages
2014 Analysis of Symrise
US$ 1,960.00
This strategic assessment of Symrise, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...
November 2013
70 pages
2014 Analysis of Takasago
US$ 1,960.00
This strategic assessment of Takasago, one of the world’s leading flavor and fragrance companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report from Venture Planning Group presents a ...
November 2013
46 pages
2014 Tumor Markers Testing Market: Strategic Assessments of Major Suppliers
US$ 2,000.00
This new 80-page report from Venture Planning Group provides insightful analyses of major current and emerging suppliers of tumor marker diagnostic instruments and reagents. The assessments include: Sales Product portfolios Distribution tactics Technological know-how New products in R&D Collaborative ...
November 2013
80 pages
2014 Microbiology Testing Market: Strategic Assessments of Leading Strategic Suppliers
US$ 1,480.00
This report presents strategic assessments of leading market players and emerging suppliers with innovative technologies and products in terms of their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Contains ...
November 2013
90 pages
2014 Coagulation Testing Market: Strategic Assessments of Major Suppliers
US$ 2,000.00
This report presents analyses of major current and emerging suppliers of coagulation products in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 45 pages
November 2013
45 pages
2014 Analysis of Leading Diagnostic Imaging Suppliers' Strategic Directions
US$ 2,000.00
This new report from Venture Planning Group provides strategic directions of global diagnostic imaging companies. The report presents insightful strategic assessments, including: Business, new product development, and marketing strategies. Anticipated acquisitions, joint ventures, and divestitures. The ...
November 2013
41 pages
2014 Analysis of the European HIV/AIDS Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs - Supplier Shares and Sales Forecasts For Immunodiagnostic and NAT Procedures
US$ 3,160.00
... DataPack (test volumes, sales forecasts, supplier shares) $2,500. Summary This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). For each country, the report provides test volume and sales forecasts for HIV-1/2, HIV Ag, NAT, Western ...
November 2013
277 pages
2014 Analysis of the US Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
US$ 3,120.00
Complete report $3,900. DataPack (test volumes, sales forecasts, supplier shares) $2,500. The report presents a detailed analysis of the Hepatitis diagnostics market in the US. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. The report provides five-year test ...
November 2013
241 pages
2014 Analysis of the European Hepatitis Diagnostics Market: Hospitals, Blood Banks, Public Health Labs, Commercial Labs, Physician Offices - Supplier Shares and Sales Forecasts For 10 Immunodiagnostic and NAT Procedures
US$ 5,520.00
Complete report $6,900. DataPack (test volumes, sales forecasts, supplier shares) $4,500. The report presents a detailed analysis of the Hepatitis diagnostics market in Europe, (France, Germany, Italy, Spain, UK). Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed. ...
November 2013
295 pages
2014 Analysis of the European Pap Smear/HPV Market
US$ 2,280.00
... . DataPack (test volumes, sales forecasts) $1,850. This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical significance and current laboratory practice; as well as five-year test volume ...
November 2013
235 pages
2014 Analysis of the European Cell Surface Marker Testing Market: Hospitals, Commercial Labs, Ambulatory Care Centers
US$ 3,080.00
... $2,500. The report provides an overview of the cell surface marker testing in Europe (France, Germany, Italy, Spain, UK), including 5-year forecasts for CD4, CD8 ... and the analysis itself. This report presents a detailed overview of the CD4, CD8 and CD34 Cell Surface Marker testing in five European countries ...
November 2013
125 pages
2014 Analysis of the US Point-of-Care Infectious Disease Diagnostics Market: Physician Offices/Group Practices, Emergency Rooms, Ambulatory Care Centers, Surgery Centers, Birth Centers
US$ 4,400.00
... and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of five POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test ...
November 2013
795 pages
2014 Analysis of the US Point-of-Care Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major hematology and flow cytometry ...
November 2013
238 pages
2014 Analysis of the US Point-of-Care Clinical Chemistry Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major clinical chemistry reagent and ...
November 2013
373 pages
2014 Analysis of the US Point-of-Care Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 4,400.00
... hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends, ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major coagulation reagent and instrument ...
November 2013
418 pages
2014 Analysis of the US PT and APTT Point-of-Care Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 2,320.00
... from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis Review of nine POC market segments, including their dynamics, trends ... Centers Nursing Homes Birth Centers Sales and Market Share Analysis Sales and market shares of major reagent and instrument suppliers ...
November 2013
337 pages
2014 Analysis of the UK Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers
US$ 4,880.00
Complete report $5,400. DataPack (test volumes, sales forecasts, supplier shares) $1,950. Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
November 2013
575 pages
2014 Analysis of the US Tumor Marker Testing Market: Innovations, Trends and Opportunities for Suppliers
US$ 7,760.00
Complete report $8,700. DataPack (test volumes, sales forecasts, supplier shares) $3,450. Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological ...
November 2013
620 pages
